Echo Therapeutics, Clinical Study of Its Symphony Continuous Transdermal Glucose Monitoring System

Jan. 2 , 2008 - Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE ) announced that it has started the second clinical study of its current Symphony(TM) Continuous Transdermal Glucose Monitoring System (CTGM System) at the Tufts-New England Medical Center (Tufts-NEMC). The Company expects to announce the results of the study in the first quarter of 2008. Echo's current generation Symphony CTGM System consists of the FDA-cleared SonoPrep skin permeation device that incorporates patented and leading-edge permeation control technology, together with wireless conductivity and proprietary transdermal sensor technologies... [PDF] Echo Therapeutics' Press Release-